- Home
- Publications
- Publication Search
- Publication Details
Title
In vivo generated human CAR T cells eradicate tumor cells
Authors
Keywords
-
Journal
OncoImmunology
Volume 8, Issue 12, Pages e1671761
Publisher
Informa UK Limited
Online
2019-10-11
DOI
10.1080/2162402x.2019.1671761
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CARs of the future
- (2019) Anthony F. Daniyan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia
- (2018) Franziska Blaeschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene
- (2018) Monica Casucci et al. Frontiers in Immunology
- In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
- (2018) Anett Pfeiffer et al. EMBO Molecular Medicine
- Extracellular Production of a Potent and Chemically Resistant Nattokinase in Immobilized Escherichia coli Using Response Surface Methodology
- (2018) Fatemeh Mohammadi et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Regulatory watch: European regulatory experience with advanced therapy medicinal products
- (2018) Lisbeth Barkholt et al. NATURE REVIEWS DRUG DISCOVERY
- In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
- (2017) Tyrel T. Smith et al. Nature Nanotechnology
- Chimeric antigen receptor T-cells for B-cell malignancies
- (2017) Eben I. Lichtman et al. Translational Research
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer
- (2016) Yu Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
- (2016) X. Wang et al. BLOOD
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Neutrophils in Measles Virus–mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSF
- (2016) Aditi Dey et al. MOLECULAR THERAPY
- Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment
- (2016) Ruben R. Bender et al. PLoS Pathogens
- T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing
- (2012) Q. Zhou et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started